Kommentar
Does long-term metformin usage reduce gastric cancer risk?
The Turkish Journal of Gastroenterology · 2014
DOI: 10.5152/tjg.2014.0006 ↗Kurz gefasst
Kommentar in der Zeitschrift The Turkish Journal of Gastroenterology, 2014. Verfasst von Sahin Coban. Beteiligte Einrichtung: Department of Gastroenterology, Dışkapı Yıldırım Beyazıt Education and Research Hospital, Ankara, Turkey.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Diabetes Mellitus, Type 2FemaleHumansHypoglycemic AgentsMaleMetforminStomach Neoplasms
Substanzen
Hypoglycemic AgentsMetformin
Autor:innen und Institutionen
- Department of Gastroenterology, Dışkapı Yıldırım Beyazıt Education and Research Hospital, Ankara, Turkey.
Zitieren
APA
Coban, S. (2014). Does long-term metformin usage reduce gastric cancer risk?. The Turkish Journal of Gastroenterology. https://doi.org/10.5152/tjg.2014.0006
Vancouver
Coban S. Does long-term metformin usage reduce gastric cancer risk?. The Turkish Journal of Gastroenterology. 2014. doi:10.5152/tjg.2014.0006
BibTeX
@article{Coban2014,
author = {Coban, Sahin},
title = {Does long-term metformin usage reduce gastric cancer risk?},
journal = {The Turkish Journal of Gastroenterology},
year = {2014},
doi = {10.5152/tjg.2014.0006}
}
EUVIMED